Experimental pill shows promise in shrinking esophageal tumors before surgery
Disease control
Terminated
This study tests whether adding a pill called vactosertib to standard chemoradiotherapy can improve outcomes for people with esophageal cancer. Participants take vactosertib for two weeks before and after standard treatment, then undergo surgery. The goal is to see if the drug he…
Phase: PHASE2 • Sponsor: Melissa Lumish • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC